These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 20691492)

  • 1. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
    Mayr R; Janecke AR; Schranz M; Griffiths WJ; Vogel W; Pietrangelo A; Zoller H
    J Hepatol; 2010 Nov; 53(5):941-9. PubMed ID: 20691492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
    Koyama C; Wakusawa S; Hayashi H; Ueno T; Suzuki R; Yano M; Saito H; Okazaki T
    Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
    Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
    Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China.
    Zhang W; Xu A; Li Y; Zhao S; Zhou D; Wu L; Zhang B; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Nan Y; You H; Jia J; Ou X; Huang J;
    Liver Int; 2019 Jun; 39(6):1120-1127. PubMed ID: 30500107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro.
    Moreno-Carralero MI; Muñoz-Muñoz JA; Cuadrado-Grande N; López-Rodríguez R; José Hernández-Alfaro M; del-Castillo-Rueda A; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
    Am J Hematol; 2014 Jul; 89(7):689-94. PubMed ID: 24644245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV.
    Speletas M; Kioumi A; Loules G; Hytiroglou P; Tsitouridis J; Christakis J; Germenis AE
    Blood Cells Mol Dis; 2008; 40(3):353-9. PubMed ID: 17997113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene.
    Gordeuk VR; Caleffi A; Corradini E; Ferrara F; Jones RA; Castro O; Onyekwere O; Kittles R; Pignatti E; Montosi G; Garuti C; Gangaidzo IT; Gomo ZA; Moyo VM; Rouault TA; MacPhail P; Pietrangelo A
    Blood Cells Mol Dis; 2003; 31(3):299-304. PubMed ID: 14636642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel mutations in the SLC40A1 and HFE genes implicated in iron overload in a Spanish man.
    Del-Castillo-Rueda A; Moreno-Carralero MI; Alvarez-Sala-Walther LA; Cuadrado-Grande N; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
    Eur J Haematol; 2011 Mar; 86(3):260-4. PubMed ID: 21175851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report.
    Nishina S; Tomiyama Y; Ikuta K; Tatsumi Y; Toki Y; Kato A; Kato K; Yoshioka N; Sasaki K; Hara Y; Hino K
    BMC Gastroenterol; 2021 Mar; 21(1):111. PubMed ID: 33673803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroportin diseases: functional studies, a link between genetic and clinical phenotype.
    Détivaud L; Island ML; Jouanolle AM; Ropert M; Bardou-Jacquet E; Le Lan C; Mosser A; Leroyer P; Deugnier Y; David V; Brissot P; Loréal O
    Hum Mutat; 2013 Nov; 34(11):1529-36. PubMed ID: 23943237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
    Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
    Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations of the ferroportin gene (SLC40A1): analysis of 56 consecutive patients with unexplained iron overload.
    Pelucchi S; Mariani R; Salvioni A; Bonfadini S; Riva A; Bertola F; Trombini P; Piperno A
    Clin Genet; 2008 Feb; 73(2):171-8. PubMed ID: 18177470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex and acquired cofactors determine phenotypes of ferroportin disease.
    Le Lan C; Mosser A; Ropert M; Detivaud L; Loustaud-Ratti V; Vital-Durand D; Roget L; Bardou-Jacquet E; Turlin B; David V; Loréal O; Deugnier Y; Brissot P; Jouanolle AM
    Gastroenterology; 2011 Apr; 140(4):1199-1207.e1-2. PubMed ID: 21199650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
    Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
    Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The
    Ka C; Guellec J; Pepermans X; Kannengiesser C; Ged C; Wuyts W; Cassiman D; de Ledinghen V; Varet B; de Kerguenec C; Oudin C; Gourlaouen I; Lefebvre T; Férec C; Callebaut I; Le Gac G
    Haematologica; 2018 Nov; 103(11):1796-1805. PubMed ID: 30002125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
    Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
    Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological study of Japanese patients with genetic iron overload syndromes.
    Hattori A; Miyajima H; Tomosugi N; Tatsumi Y; Hayashi H; Wakusawa S
    Pathol Int; 2012 Sep; 62(9):612-8. PubMed ID: 22924847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of iron overload during pregnancy and childbirth in a patient with ferroportin disease].
    Ohara K; Tsuge N; Watanabe S; Eda H; Ogasawara F; Kondo T; Yoshida S; Kojima K
    Rinsho Ketsueki; 2023; 64(11):1410-1414. PubMed ID: 38072426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ferroportin disease.
    Pietrangelo A
    Blood Cells Mol Dis; 2004; 32(1):131-8. PubMed ID: 14757427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel ferroportin mutation in a Canadian family with autosomal dominant hemochromatosis.
    Morris TJ; Litvinova MM; Ralston D; Mattman A; Holmes D; Lockitch G
    Blood Cells Mol Dis; 2005; 35(3):309-14. PubMed ID: 16111902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.